This Article Full Text Full Text (PDF) All Versions of this Article: 92/7/2811    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rindi, G. Articles by Ferri, G.-L. Search for Related Content PubMed PubMed Citation Articles by Rindi, G. Articles by Ferri, G.-L. Related Collections Adrenal and Hypertension Endocrine Oncology

Peptide Products of the Neurotrophin-Inducible Gene vgf Are Produced in Human Neuroendocrine Cells from Early Development and Increase in Hyperplasia and Neoplasia

Department of Pathology and Laboratory Medicine (G.R., L.B., N.C., C.A., G.G.), University of Parma, 43100 Parma, Italy; Surgical Pathology Service (L.L., M.F.), Ospedale Leno-Manerbio, 25024 Leno (BS), Italy; Department of Human Pathology and Genetics (V.N., E.S.), University of Pavia, 27100 Pavia, Italy; and NEF Laboratory (F.D., C.B., G.-L.F.), Department of Cytomorphology, University of Cagliari, 09042 Monserrato (CA), Italy

Address all correspondence and requests for reprints to: Guido Rindi, M.D., Ph.D., Dipartimento di Patologia e Medicina di Laboratorio, Sezione di Anatomia Patologica, Università di Parma, Via Gramsci, 14, I-43100 Parma, Italy. E-mail: guido.rindi{at}unipr.it.

Background: Although the neurotrophin-inducible gene vgf is expressed in mammalian neurons and endocrine cells, limited data is available in man.

Aim: The objective of the study was to map proVGF peptides in human endocrine cells during development, adulthood, hyperplasia, and tumors.

Methods: Antisera were generated against peptides related to internal cleavage or cleavage-amidation sites (rat proVGF_422–430 and human proVGF_298–306-NH2) and the proVGF C-terminal ending (human proVGF_607–615). Developing and normal adult endocrine cells, hyperplastic endocrine lesions (thyroid, parathyroid, lung, and stomach), and 120 tumors (102 endocrine) were studied. Immunogold electron microscopy was performed on normal adult pancreas and gut, and Western blotting was performed on extracts of control tissues and endocrine tumors.

Results: proVGF fragments were revealed in developing pituitary, gut, pancreas, and adrenal medulla from 10 gestational weeks, in normal adult pituitary and adrenal medulla, pancreatic glucagon, and insulin cells and gut serotonin cells, in hyperplastic thyroid calcitonin cells, lung P cells, gastric enterochromaffin-like cells, and gastrin cells, and in 88 of 102 endocrine tumors. At electron microscopy proVGF immunoreactivity was restricted to electron-dense granules. Western blotting revealed large molecular weight forms and cleavage fragments in both control tissues and tumor extracts.

Conclusions: proVGF-related peptides are present in endocrine cells early during development and adulthood and increase in hyperplasia and tumors, and proVGF fragments could be novel diagnostic tools for endocrine cells and related lesions, including tumors.

This article has been cited by other articles:

				F. D'Amato, B. Noli, C. Brancia, C. Cocco, G. Flore, M. Collu, P. Nicolussi, and G.-L. Ferri Differential distribution of VGF-derived peptides in the adrenal medulla and evidence for their selective modulation J. Endocrinol., May 1, 2008; 197(2): 359 - 369. [Abstract] [Full Text] [PDF]